US 10035802
Solid state forms of ibrutinib
granted A61KA61K31/519A61P
Quick answer
US patent 10035802 (Solid state forms of ibrutinib) held by Teva Pharmaceuticals USA, Inc. expires Mon Jul 26 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Teva Pharmaceuticals USA, Inc.
- Grant date
- Tue Jul 31 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 26 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 14
- CPC classes
- A61K, A61K31/519, A61P, A61P35/00